Press releasePRNewswire
Illumina
ILMN · NASDAQ
$267.93+$5.27 (+2.01%)TodayMarket closed ·
Prev close $262.66
News sentiment
Tone of recent coverage
Social media sentiment, last 30 days
Average tone of posts mentioning ILMN, from −1 (all negative) to +1 (all positive). Latest day: +0.00 across 29 mentions.
Latest news
- Press releasePRNewswire
Illumina launches BioInsight Platform, its first unified software environment to help accelerate genomic and multiomic breakthroughs
- Press releasePRNewswire
Illumina to Announce Third Quarter 2026 Financial Results on Thursday, October 29, 2026
- Press releasePRNewswire
Illumina releases SpliceAI2 to help advance rare disease research
- News
Illumina Reports Q2 2026 Results: Full Earnings Call Transcript
- NewsAvi Kapoor
LuxExperience, Alvotech, Twist Bioscience And Other Big Stocks Moving Higher On Wednesday
- NewsPiero Cingari
10-Year Yield Tops 5%, Oil Storms Past $105: Stock Market Today
- Press releasePRNewswire
Bloom Energy, Illumina, and Everpure Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600
- Press releaseGlobe Newswire
The Market Just Told You Which Layer Of AI Biology It Is Paying For
- NewsPiero Cingari
Bessent's Bond Rescue Fizzles, Walmart Craters 9%: Stock Market Today
- Press releasePRNewswire
Illumina Reports Financial Results for Second Quarter of Fiscal Year 2026
- NewsChandrima Sanyal
New AI ETF Bets on Healthcare's $9 Trillion Opportunity
- Press releasePRNewswire
Illumina expands Billion Cell Atlas program with new AI drug developers
- Press releasePRNewswire
Illumina to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026
- Press releasePRNewswire
Illumina appoints Michael Sullivan Chief Commercial Officer and Julie Coletti Chief Legal Officer
- Press releasePRNewswire
Daniel M. Skovronsky, MD, PhD, appointed to Illumina's Board of Directors
- Press releaseBusiness Wire
IQM Appoints Craig Ciesla, Former Illumina VP, as CTO; Inés de Vega Becomes Chief Scientist
- Press releasePRNewswire
Illumina launches StrataMap Spatial Solution, a powerful end-to-end spatial whole transcriptome research solution
- Press releaseBusiness Wire
Integrated DNA Technologies Announces End-to-End Oncology Research Workflows Optimized on Illumina Software for Faster Insights
- Press releasePRNewswire
Illumina and SPT Labtech unveil fireflyGO, enabling faster, simpler targeted oncology research
- Press releasePRNewswire
Illumina introduces the first distributed whole-genome sequencing solution for highly sensitive MRD research
- Press releasePRNewswire
David P. King elected to Illumina's Board of Directors
- Press releasePRNewswire
Illumina releases 2025 Corporate Responsibility Report, expanding access to genomics and accelerating global impact
- NewsErica Kollmann
Trump Lands In China With $16 Trillion Of CEO Power — And One Big Ask For Xi
- NewsAvi Kapoor
Uber, Exxon Mobil, Illumina, Diamondback Energy: CNBC's 'Final Trades'
- Press releasePRNewswire
Illumina Reports Financial Results for First Quarter of Fiscal Year 2026
- Press releasePRNewswire
DRAGEN v4.5 supports Illumina's new TruPath Genome and 5-base assays, drives insights across germline, oncology, and multiomic workflows
- Press releasePRNewswire
Illumina and the Center for Data-Driven Discovery in Biomedicine bring genomic data and scalable software to the fight against pediatric cancer and rare disease
- Press releasePRNewswire
Illumina to Announce First Quarter 2026 Financial Results on Thursday, April 30, 2026
- Press releasePRNewswire
Illumina Announces Changes to Board of Directors
- Press releasePRNewswire
Illumina and Labcorp expand collaboration to broaden access to precision oncology testing
- Press releasePRNewswire
Illumina advances preventive genomics through strategic consortium with Veritas Genetics
- News
Earnings Scheduled For February 5, 2026
- NewsAvi Kapoor
Dow Falls Over 100 Points; Amazon Posts Upbeat Q3 Results
- NewsAvi Kapoor
Cloudflare Posts Upbeat Q3 Results, Joins Amazon, Roku, Coinbase, Atlassian And Other Big Stocks Moving Higher On Friday
- NewsSurbhi Jain
Icahn Hedge Fund's Q2 Moves: Centuri Stake Soars, JetBlue Held, 2 Positions Exited
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.